Drug Shortage Report for AMERGE

Last updated on 2017-08-18 History
Report ID 12800
Drug Identification Number 02237820
Brand name AMERGE
Common or Proper name naratriptan hydrochloride tablets
Company Name GLAXOSMITHKLINE INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) NARATRIPTAN
Strength(s) 1MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 2's
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-06-26
Estimated end date 2017-08-23
Actual end date 2017-08-17
Shortage status Resolved
Updated date 2017-08-18
Company comments
Health Canada comments
Tier 3 Status No
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-06-15 English Compare
v2 2017-06-15 French Compare
v3 2017-06-21 English Compare
v4 2017-06-21 French Compare
v5 2017-06-27 English Compare
v6 2017-06-28 English Compare
v7 2017-06-28 French Compare
v8 2017-07-05 English Compare
v9 2017-07-05 French Compare
v10 2017-07-19 English Compare
v11 2017-07-19 French Compare
v12 2017-08-02 English Compare
v13 2017-08-02 French Compare
v14 2017-08-09 English Compare
v15 2017-08-09 French Compare
v16 2017-08-18 English Compare
v17 2017-08-18 French Compare

Showing 1 to 17 of 17